Diagnosing PD Is Primarily A Clinical Process
a CLINICAL Experience
Simply put, a diagnosis is described as “clinical,” it means this: It’s based on expert observation and pattern recognition—not a single test.
For Parkinson’s, there is no blood test, scan, or lab result that can definitively confirm the diagnosis on its own.
Instead, a clinician—usually a neurologist—use:
- Your medical history
- Your symptoms and how they’ve evolved
- A hands-on neurological exam
- Repeated observations over time
- How symptoms respond to treatment (when tried)
- Tests or imaging to rule out other conditions, not to “prove” Parkinson’s
Think of it like this:
A lab or imaging test is a snapshot.
A clinical diagnosis is the movie.
What to expect at you initial neurological Exam
Before you’re even aware the exam has started, the neurologist is observing.
THE INITIAL CONSULTATION
- How you sit and stand – ease of movement, stiffness, hesitation, or extra effort
- Facial expression and blinking – reduced expression or infrequent blinking
- Arm swing and posture – reduced arm swing, asymmetry, or subtle stooping
- Resting tremor – tremor present at rest that changes with movement
These observations often reveal patterns that structured tests alone can’t—and help guide the rest of the exam.
The exam should include a review of your medical history, along with your symptoms and how they’ve changed over time. When symptoms began, how they’ve progressed, and what makes them better or worse all provide important context and help the neurologist interpret what they see during the exam.
Bradykinesia—slowness of movement—is a core feature of Parkinson’s disease.
Repetitive Movement
Speed
- Tapping your fingers together quickly
- Opening and closing your hand repeatedly
- Tapping your foot on the floor
While these tasks may seem straightforward, the neurologist is observing several subtle details at the same time. They are looking for slowing as the movement continues, a gradual decrease in movement size or amplitude, hesitation when starting or stopping, and fatigue that appears with repetition. Consistency matters as much as speed.
- Differences between the right and left sides
- Movements becoming smaller, less coordinated, or less rhythmic
- A delay between intention and execution
Importantly, this isn’t about how fast you move at the start—it’s about how movement changes over time. These patterns help distinguish Parkinson’s-related bradykinesia from normal slowing, stiffness, or weakness.
- Arms and wrists
- Neck
- Legs
During this part of the exam, the neurologist will ask you to relax completely while they gently move different parts of your body, including your:
Rigidity & Muscle Tone
The goal is to assess muscle tone, not strength. As your limbs are moved, the neurologist is feeling for resistance to passive movement—a hallmark feature of Parkinson’s disease.
They are specifically looking for:
- Uniform stiffness throughout the range of motion (rigidity)
- The class`hety rather than smooth
- Asymmetry, with one side of the body often more affected than the other
The neurologist may repeat these movements or ask you to perform a simple task with the opposite limb (such as opening and closing your hand) to see if rigidity becomes more apparent, a phenomenon known as activation.
Importantly, rigidity in Parkinson’s is different from spasticity or joint problems. These findings help the neurologist distinguish Parkinson’s disease from other neurologic or musculoskeletal conditions.
- Tremor at rest – when your hands, arms, or legs are relaxed and supported
- Tremor while holding a posture – such as holding your arms outstretched
- Tremor during movement – while reaching for or manipulating an object
During this portion of the exam, the neurologist carefully observes how tremor appears in different situations, including:
TREMOR EVALUATION
The neurologist is assessing the timing, pattern, and distribution of the tremor. Parkinson’s tremor most often appears at rest and may decrease or temporarily disappear with movement, while other tremor types—such as essential tremor—are more prominent during action or posture.
- Tremor affecting one side more than the other
- A tremor that changes with distraction or mental tasks
- Subtle re-emergence of tremor after holding a posture for several seconds
These details help distinguish Parkinson’s-related tremor from essential tremor and other neurologic conditions. Importantly, not everyone with Parkinson’s has a visible tremor, and the absence of tremor does not rule out the disease.
- Walk down a hallway and turn
- Walk heel-to-toe
- Stop and start walking on command
- Take a few steps backward when gently pulled (postural reflex test)
During this part of the exam, the neurologist evaluates how your body moves while walking, stopping, turning, and maintaining balance. You may be asked to:
Gait, Balance & Posture
While you perform these tasks, the neurologist is observing multiple features at once. They are assessing stride length, walking speed, foot clearance, and whether steps become shorter or shuffling. Turning style is closely watched, including whether you pivot smoothly or need several small steps to change direction.
They also look for:
Posture, including forward stooping or stiffness
Arm swing, which is often reduced or asymmetric in Parkinson’s
Balance responses, especially how quickly and effectively you recover when gently pulled backward
Hesitation or freezing when starting, stopping, or turning
- Voice volume and clarity, listening for a softer or fading voice (hypophonia)
- Facial expressiveness, noting reduced facial movement or a “masked” appearance
- Speech rhythm, including changes in pace, articulation, or monotone delivery
During this part of the exam, the neurologist looks beyond limb movement to assess how Parkinson’s can affect communication, expression, and internal body functions. They may evaluate:
Speech/Facial & Non-Movement
These features can be subtle and are often noticed more by others than by the person experiencing them.
In addition to what can be observed, the neurologist will ask targeted questions about non-motor symptoms, which are an important part of Parkinson’s disease and often appear years before movement changes. These may include:
- Sleep changes, especially REM sleep behavior disorder, where people act out dreams
- Changes in sense of smell, often reduced long before diagnosis
- Constipation, reflecting slowed autonomic function
- Mood or anxiety changes, such as depression or apathy
- Cognitive or attention changes, including slowed thinking or difficulty multitasking
These non-motor features provide critical context and help support the diagnosis, even when motor symptoms are mild. Together with the movement exam, they help the neurologist identify a consistent pattern rather than relying on any single finding.
A movement-disorder neurologist is not looking for one isolated sign. They are looking for a pattern of features that fit together, including:
There is no single test that can diagnose Parkinson’s disease. Instead, diagnosis is a clinical process that unfolds through careful observation, pattern recognition, and follow-up over time.
The Big Picture
- A recognizable pattern of symptoms, both motor and non-motor
- Asymmetry, with one side of the body typically more affected than the other
- Progression over time, rather than symptoms appearing all at once
- Response to medication, particularly improvement with dopamine-based treatments
- Absence of red flags that would suggest another neurologic condition
Just as important is what doesn’t appear during the exam or on supporting tests. Normal imaging or lab results don’t rule out Parkinson’s—they often help confirm that symptoms aren’t caused by something else.
For many people, diagnosis doesn’t happen in a single visit. It often unfolds over multiple appointments, as patterns become clearer and changes over time provide additional insight. This step-by-step approach is intentional—and it’s one of the reasons experience with Parkinson’s matters.
TESTS THAT MAY BE USED To support diagnosis
SUPPORT DIAGNOS
Either before or after your first neurological exam, if Parkinson’s is suspected, your provider may order certain tests—not to confirm Parkinson’s, but to exclude other possible causes of your symptoms.
Targeted PD Gene Panels
05
04
Positron Emission Tomography (PET)
03
Magnetic Resonance Imaging MRI
02
Laboratory Testing - Blood Work
01
- Thyroid function (hypo- or Hyperthyroidism can affect movement and energy)
- Vitamin deficiencies, especially B12 and folate, which can cause balance, nerve, or cognitive issues
- Electrolyte imbalances (such as sodium or calcium abnormalities)
- Liver and kidney function, which can affect toxin clearance and medication response
- Inflammatory or Autoimmune Markers, when symptoms raise concern for other neurologic or systemic conditions
- Infectious causes, if history or presentation suggests exposure.
Blood tests – used to rule out metabolic, infectious, autoimmune, or nutritional conditions that can mimic Parkinson’s symptoms. These may include tests for:
There is no blood test that confirms Parkinson’s Disease. These tests are used to exclude other conditions that can look similar, helping clinicians narrow the diagnosis through a process of elimination.
Laboratory Testing- Blood Work
01
Magnetic Resonance Imaging (MRI)
02
Positron Emission Tomography (PET)
03
Computed Tomography (CT) Scan
04
Targeted PD Gene Panels
05
In most people with Parkinson’s, the MRI appears normal, especially early in the disease. That normal result is still useful—it helps confirm that symptoms are not being caused by another structural problem. While MRI cannot diagnose Parkinson’s or show Dopamine loss, it plays an important role in excluding look-alike conditions, guiding diagnosis, and informing next steps in care.
An MRI is commonly used in the evaluation of Parkinson’s to rule out other conditions that can cause similar symptoms.
Positron Emission Tomography (PET)
03
Targeted PD Gene Panel
05
Laboratory Testing- Blood Work
01
Magnetic Resonance Imaging (MRI)
02
Computed Tomography (CT) Scan
04
These scans can be helpful when the diagnosis is uncertain, especially in early or atypical cases, or when trying to distinguish Parkinson’s from conditions such as essential tremor.
These specialized imaging tests are sometimes used to evaluate Dopamine signaling in the brain,
Computed Tomography (CT) Scan
04
Laboratory Testing- Blood Work
01
Magnetic Resonance Imaging MRI
02
Positron Emission Tomography (PET)
03
Targeted PD Gene Panels
05
CT scans are used less commonly in the evaluation of Parkinson’s Disease.
Targeted PD Gene Panels
05
Laboratory Testing- Blood Work
01
Magnetic Resonance Imaging (MRI)
02
Positron Emission Tomography (PET)
03
Computed Tomography (CT) Scan
04
Most genetic testing for Parkinson’s uses a targeted gene panel,
Commonly tested genes include:
LRRK2 – the most common genetic cause of Parkinson’s worldwide
GBA – increases risk and may influence symptom progression
PARK2 (Parkin) – often linked to younger-onset Parkinson’s
PINK1 – associated with early-onset forms
SNCA – rare, but directly involved in Alpha-Synuclein production
These panels focus only on genes with established relevance, rather than sequencing everything.
A Biomarker is a measurable substance or characteristic in the body that provides information about health or disease.
Example:
High cholesterol is a Biomarker that signals increased risk for heart disease.
Biomarkers can be found in blood, urine, cerebrospinal fluid, skin, or tissue.
For Parkinson’s, Biomarker research is still evolving, but it is becoming increasingly important for improving diagnosis, research, and clinical trials.
6. What Are The Key Takeaways?
5. Describe a Syn-One Skin Biopsy Test?
4. Describe Alpha-Synuclein Seed Amplification Assay Test?
3. Are There Biomarker Tests for Parkinson’s?
A
Q
6. What Are The Key Takeaways?
5. Describe a Syn-One Skin Biopsy Test?
4. Describe Alpha-Synuclein Seed Amplification Assay Test?
3. Are There Biomarker Tests for Parkinson’s?
- Symptoms
- Medical history
- Neurological examination
- Response to medications
A
Q
6. What Are The Key Takeaways?
5. Describe a Syn-One Skin Biopsy Test?
4. Describe Alpha-Synuclein Seed Amplification Assay Test?
Biomarker tests do not diagnose Parkinson’s on their own, but they can give healthcare providers additional clues. Two emerging tests you may hear about are the Alpha-Synuclein Seed Amplification Assay (SAA) and the Syn-One Skin Biopsy Test. Both look for abnormal forms of the protein Alpha-Synuclein, a key protein involved in Parkinson’s Disease.
3. Are There Biomarker Tests for Parkinson’s?
A
Q
6. What Are The Key Takeaways?
5. Describe a Syn-One Skin Biopsy Test?
4. Describe Alpha-Synuclein Seed Amplification Assay Test?
- Sample: Cerebrospinal fluid (CSF)
- How it’s collected: Lumbar puncture (spinal tap)
This test looks for misfolded Alpha-Synuclein proteins in Cerebrospinal Fluid, which surrounds the brain and spinal cord. During the procedure, a healthcare provider inserts a needle into the lower spine to collect a small amount of fluid.
The presence of misfolded Alpha-Synuclein can suggest an underlying Parkinson’s-related process, but the test is not diagnostic on its own and must be interpreted alongside clinical findings.
.
3. Are There Biomarker Tests for Parkinson’s?
A
Q
6. What Are The Key Takeaways?
5. Describe a Syn-One Skin Biopsy Test?
4. Describe Alpha-Synuclein Seed Amplification Assay Test?
- Sample: Small skin and nerve tissue samples
- How it’s collected: Minor outpatient skin biopsy
This test involves taking small skin samples from the back and legs that contain surface nerve fibers. These samples are examined for abnormal Alpha-Synuclein deposits in the nerves.
Results may help determine whether Alpha-Synuclein is behaving abnormally in the nervous system and can support a Parkinson’s or related Synucleinopathy diagnosis when combined with clinical evaluation.
3. Are There Biomarker Tests for Parkinson’s?
A
Q
6. What Are The Key Takeaways?
5. Describe a Syn-One Skin Biopsy Test?
4. Describe Alpha-Synuclein Seed Amplification Assay Test?
As mentioned, Parkinson’s is diagnosed based on clinical judgment, not a single test. Biomarkers like SAA and Syn-One represent promising tools that may improve diagnostic confidence and research, but they are supporting pieces of the puzzle, not standalone answers.
